Leveling Up Tech Transfer Training with DCVMN for 7 Asian Countries

View Gallery

First Look Hilleman launches ACES cGMP facility

View Gallery

Working Together Capability Building Initiatives

Explore

Leveraging Technology Hilleman to lead development of an mRNA vaccine for HFMD

Read More

Our Focus

Numerous barriers hamper access to life-saving vaccines for millions of people living in the developing world. At our new global headquarters in Singapore, Hilleman Laboratories translates early discovery of vaccines and biologics for infectious diseases into affordable products with global health impact. Our focus on global health access means we prioritize effective delivery of high impact products and ensure wide access in under-served regions.

Read more
ELEVATE YOUR
CAREER
image Be part of our team
Latest Press Releases
View more